Smart Computing Models, Sensors, and Early Diagnostic Speech and Language Deficiencies Indicators in Child Communication
NCT06633874
Articulation Disorders, Communication Disorders
Ioannina, Greece
View Trial DetailsNCT Number: NCT00001551
According to studies, speech disorders with unknown causes (idiopathic) affect approximately 5% of the population at some point in their life. Some of these disorders like, stuttering and cluttering, are known for being detected early, during speech development.
Stuttering is characterized by sound and syllable repetitions and consonant/vowel prolongations. When stuttering is moderate to severe, it can interfere with a person's job and social activities.
Speech articulation disorders are characterized by omissions, or substitutions of speech sounds. The speech of a person who clutters is often difficult to understand. People are often unaware of the errors they make when speaking causing treatment of the condition to be very difficult.
The purpose of this research is to study an extended family whose members exhibit a pure form of speech articulation disorders
In addition, the study will use data and information gathered from the study and use it to develop guidelines (criteria) for defining and differentiating patients with speech disorders.
Looking for future studies?
Notify MeAll sexes
Observational
University of Maryland, College Park, College Park, Maryland, United States
Objective:
Our objective is to determine which factors are involved in the development of stuttering and familial phonological processing disorder and are associated with a familial pattern of inheritance.
Study population: The study population is comprised of 8 groups:
Design: A Natural history design will be used to compare affected and unaffected family members with healthy volunteers with normal speech and language.
Outcome Measures: Genetic markers and pedigree analyses will be used to test familial inheritance patterns. Speech and language development will be compared using indices of speech perception, auditory perception, self monitoring of one's own speech, language complexity, motor complexity, speech learning, phonological processing and verbal/nonverbal memory.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
-INCLUSION CRITERIA:
i. Normal Language Development, Hearing and Cognition
ii. The following screening tests previously published with norms were found to have a good distribution for determining normal functioning in adolescents and adults as all subjects did not hit ceiling and all had scores greater than or equal to the 80th percentile. These tests are being used to ensure that subjects affected with stuttering or FPPD do not have other disorders such as hearing loss, language delay, or mental retardation.
Peabody Picture Vocabulary Test III (PPVT-III)
Expressive Vocabulary Test (EVT)
Oral Speech Mechanism Screening Examination
Revised Token Test; Token test for Children
Test of Non verbal intelligence (TONI-2)
Digit Span subtest of the WICS-R
Audiometric Screening
Goldman Fristoe Test of Articulation
WUG Test of Morphological Encoding
Test of Auditory Comprehension of Language (TACL)
Khan-Lewis Phonological Analysis
Inclusion criteria
FOR IDENTIFYING AND QUANTIFYING STUTTERING:
The Stuttering Severity Index -3 (Riley, 1981) has been found to be accurate for identifying and assessing the severity of stuttering during conversational speech. For the inclusion of a stuttering subject we require:
i. A total overall score of 11 or greater between 3 and 17 years,
ii. A total overall score of 18 or greater from age 18 and above.
Inclusion criteria
FOR IDENTIFYING FPPD:
i. A family history of an autosomal dominant pattern of inheritance of the speech disorder over several generations with persistence into adulthood in some cases,
ii. Speech symptoms during conversational speech include: deletion of final consonants; syllable reduction and syllable deletion; deletion of grammatical markers such as copulas, auxiliaries, prepositions, connectives; poor ability to self-correct; poor awareness of errors; and consonant cluster reduction.
iii. Greater than 9% discourse errors during analysis of a sample of 300 syllables.
iv. A discrepancy of 30 points (1 and 1/2 Standard Deviations) between receptive (the higher score) and expressive percentile score on the PPVT III and Expressive Vocabulary Test.
v. For subjects greater than 7 years of age, a phonological process rating of 3 or more for any phonological process on the Khan-Lewis Phonological Analysis. For subjects less than 7 years of age, a phonological process rating of 3 or more on 2 phonological processes on the Khan-Lewis Phonological Analysis. Finally, any subjects with a non developmental phonological process error will be identified as potentially having FPPD.
Exclusion criteria
i. Anyone with a hearing loss will be excluded from participation during the diagnostic testing.
ii. Children with delayed language, more than 1 year delay from norms on receptive and expression language testing will be excluded.
iii. Language impairment: scores more than 2 standard deviations below the age appropriate score on the standardized language tests listed under the inclusion criteria.
iv. Cognitive impairment: scores more than 2 standard deviations below the age appropriate score on the standardized cognitive tests listed under the inclusion criteria.
v. Bilingual non-native English speakers - Studies have demonstrated that brain organization for speech and language may differ in bilingual persons. It is hypothesized that this may alter speech motor learning and thus kinematic data from non-native English speakers would differ from native English speakers. Therefore, only native-American English speakers, with only one language spoken in the home, will be included.
National Institute of Neurological Disorders and Stroke (NINDS)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06633874
Articulation Disorders, Communication Disorders
Ioannina, Greece
View Trial DetailsNCT00004991
Articulation Disorders, Communication Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT02288598
Communication Disorders, Fluency Disorders
Oxford, United Kingdom
View Trial DetailsNCT05286151
Communication Disorders, Language Disorders
Ann Arbor, Michigan, United States
View Trial Details